📣 VC round data is live. Check it out!
- Public Comps
- eXoZymes
eXoZymes Valuation Multiples
Discover revenue and EBITDA valuation multiples for eXoZymes and similar public comparables like Amoeba, 5E Advanced Materials, BRAIN Biotech, Northern Technologies and more.
eXoZymes Overview
About eXoZymes
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
Founded
2019
HQ

Employees
31
Website
Sectors
Financials (FY)
EV
$80M
Valuation Multiples
Start free trialeXoZymes Financials
eXoZymes reported last fiscal year revenue of - and negative EBITDA of ($9M).
In the same fiscal year, eXoZymes generated ($9M) in EBITDA losses and had net loss of ($9M).
eXoZymes P&L
In the most recent fiscal year, eXoZymes reported revenue of - and EBITDA of ($9M).
eXoZymes is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
eXoZymes Stock Performance
eXoZymes has current market cap of $81M, and enterprise value of $80M.
Market Cap Evolution
eXoZymes' stock price is $9.50.
eXoZymes share price decreased by 3.5% in the last 30 days, and by 3.6% in the last year.
eXoZymes has an EPS (earnings per share) of $-1.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $80M | $81M | -1.7% | -3.5% | 27.7% | -3.6% | $-1.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialeXoZymes Valuation Multiples
eXoZymes trades at (8.5x) EV/EBITDA.
eXoZymes Financial Valuation Multiples
As of June 4, 2026, eXoZymes has market cap of $81M and EV of $80M.
eXoZymes has a P/E ratio of (8.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified eXoZymes Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


eXoZymes Margins & Growth Rates
eXoZymes Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
eXoZymes Operational KPIs
eXoZymes' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
eXoZymes Competitors
eXoZymes competitors include Amoeba, 5E Advanced Materials, BRAIN Biotech, Northern Technologies, American Vanguard, I-Tech, Holland, Exel Composites, Eden Innovations and Arla Plast.
Most eXoZymes public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 252.7x | 40.0x | (14.3x) | (15.4x) | |||
| - | - | (10.7x) | - | |||
| 1.2x | 1.2x | (92.3x) | 36.7x | |||
| 1.0x | 0.9x | 15.7x | - | |||
| 0.6x | 0.6x | 7.3x | 7.3x | |||
| 4.2x | 4.0x | 14.4x | 13.3x | |||
| 0.6x | - | 8.0x | - | |||
| 0.9x | 0.9x | 13.4x | 10.0x | |||
This data is available for Pro users. Sign up to see all eXoZymes competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout eXoZymes
| When was eXoZymes founded? | eXoZymes was founded in 2019. |
| Where is eXoZymes headquartered? | eXoZymes is headquartered in United States. |
| How many employees does eXoZymes have? | As of today, eXoZymes has over 31 employees. |
| Who is the CEO of eXoZymes? | eXoZymes' CEO is Michael Heltzen. |
| Is eXoZymes publicly listed? | Yes, eXoZymes is a public company listed on Nasdaq. |
| What is the stock symbol of eXoZymes? | eXoZymes trades under EXOZ ticker. |
| When did eXoZymes go public? | eXoZymes went public in 2024. |
| Who are competitors of eXoZymes? | eXoZymes main competitors include Amoeba, 5E Advanced Materials, BRAIN Biotech, Northern Technologies, American Vanguard, I-Tech, Holland, Exel Composites, Eden Innovations, Arla Plast. |
| What is the current market cap of eXoZymes? | eXoZymes' current market cap is $81M. |
| Is eXoZymes profitable? | No, eXoZymes is not profitable. |
| How many companies eXoZymes has acquired to date? | eXoZymes hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies eXoZymes has invested to date? | eXoZymes hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to eXoZymes
Lists including eXoZymes
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.